Amanote Research
Register
Sign In
Leukemia Drug Heralds Molecularly Targeted Era
Journal of the National Cancer Institute
- United Kingdom
doi 10.1093/jnci/92.1.6
Full Text
Open PDF
Abstract
Available in
full text
Categories
Cancer Research
Oncology
Date
January 5, 2000
Authors
B. Vastag
Publisher
Oxford University Press (OUP)
Related search
Acute Myeloid Leukemia Drug Development in the Post‐Venetoclax Era
American Journal of Hematology
Hematology
Molecularly Targeted Therapy: Imatinib and Beyond
Oligonucleotide Aptamer-Drug Conjugates for Targeted Therapy of Acute Myeloid Leukemia
Biomaterials
Mechanics of Materials
Biophysics
Biomaterials
Bioengineering
Composites
Nanoscience
Nanotechnology
Ceramics
Novel Targeted Drug Therapies for the Treatment of Childhood Acute Leukemia
Expert Review of Hematology
Hematology
Post-Extraction Wound Healing Failure With Long-Term Bone Exposure Related to Sunitinib, a Molecularly Targeted Drug
Japanese Journal of Oral and Maxillofacial Surgery
Entering the Era of Targeted Therapy for Chronic Lymphocytic Leukemia: Impact on the Practicing Clinician
Journal of Clinical Oncology
Cancer Research
Medicine
Oncology
Novel Mechanisms of Resistance to Investigational Molecularly Targeted Drugs
Yakugaku Zasshi
Pharmacology
Pharmaceutical Science
Dose Determination for Molecularly Targeted Therapies: Much Ado About Nothing
Cancer
Cancer Research
Oncology
Metal-Containing Pharmacophores in Molecularly Targeted Anticancer Therapies and Diagnostics
European Journal of Inorganic Chemistry
Inorganic Chemistry
